Colony »

Compass Therapeutics shares owned by Colony

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Colony from 13F filings

Historical chart of Colony investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Colony

Quarter filed Position value Share count Share price at filing
2025-09-30 $56k 16k 3.54
2025-06-30 $35k 14k 2.60
2025-03-31 $26k 14k 1.90
2024-12-31 $20k 14k 1.45

More positions owned by Colony

Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ea Series Trust Ea Bridgeway Omn (BSVO)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Ttl Stk (ITOT)
Dimensional Etf Trust Us High Profitab (DUHP)

View all positions for Colony

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
Enavate Sciences GP
BlackRock
Vanguard Group
Adage Capital Partners GP
MPM Oncology Impact Management
BVF
Rock Springs Capital Management
FMR
Millennium Management
State Street Corporation

View all funds holding Compass Therapeutics